Sinco Pharma Declares HK$0.167 Final Dividend for FY2025

Bulletin Express03-26

Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the annual general meeting scheduled for 15 May 2026.

The stock will trade ex-dividend on 19 May 2026. Share transfers must be lodged with Computershare Hong Kong Investor Services Limited by 16:30 on 20 May 2026. The register of members will be closed from 21 May to 26 May 2026, with the record date set for 26 May 2026.

Dividend payments are slated for 4 June 2026 and will be settled in Hong Kong dollars on a one-to-one exchange basis. The company stated that no withholding tax applies to this distribution.

Sinco Pharma’s board currently comprises Executive Directors Huang Xiangbin, Lei Shifeng and Huang Zhijian; Non-executive Director Jing Huan; and Independent Non-executive Directors Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187480454?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187480454","market":"us","top_or_hot":-1,"title":"Sinco Pharma Declares HK$0.167 Final Dividend for FY2025","media":"Bulletin Express","content":"<p>Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the annual general meeting scheduled for 15 May 2026.</p>\n<p>The stock will trade ex-dividend on 19 May 2026. Share transfers must be lodged with Computershare Hong Kong Investor Services Limited by 16:30 on 20 May 2026. The register of members will be closed from 21 May to 26 May 2026, with the record date set for 26 May 2026.</p>\n<p>Dividend payments are slated for 4 June 2026 and will be settled in Hong Kong dollars on a one-to-one exchange basis. The company stated that no withholding tax applies to this distribution.</p>\n<p>Sinco Pharma’s board currently comprises Executive Directors Huang Xiangbin, Lei Shifeng and Huang Zhijian; Non-executive Director Jing Huan; and Independent Non-executive Directors Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinco Pharma Declares HK$0.167 Final Dividend for FY2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinco Pharma Declares HK$0.167 Final Dividend for FY2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-26 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the annual general meeting scheduled for 15 May 2026.</p>\n<p>The stock will trade ex-dividend on 19 May 2026. Share transfers must be lodged with Computershare Hong Kong Investor Services Limited by 16:30 on 20 May 2026. The register of members will be closed from 21 May to 26 May 2026, with the record date set for 26 May 2026.</p>\n<p>Dividend payments are slated for 4 June 2026 and will be settled in Hong Kong dollars on a one-to-one exchange basis. The company stated that no withholding tax applies to this distribution.</p>\n<p>Sinco Pharma’s board currently comprises Executive Directors Huang Xiangbin, Lei Shifeng and Huang Zhijian; Non-executive Director Jing Huan; and Independent Non-executive Directors Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06833","symbol_name":"兴科蓉医药","start_time":0,"source_url":"","article_id":"1187480454","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187480454","pubTimestamp":1774532663,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06833":"兴科蓉医药"},"translate_title":"新科制药宣派2025财年末期股息0.167港元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06833":1},"content_text":"Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the annual general meeting scheduled for 15 May 2026.\nThe stock will trade ex-dividend on 19 May 2026. Share transfers must be lodged with Computershare Hong Kong Investor Services Limited by 16:30 on 20 May 2026. The register of members will be closed from 21 May to 26 May 2026, with the record date set for 26 May 2026.\nDividend payments are slated for 4 June 2026 and will be settled in Hong Kong dollars on a one-to-one exchange basis. The company stated that no withholding tax applies to this distribution.\nSinco Pharma’s board currently comprises Executive Directors Huang Xiangbin, Lei Shifeng and Huang Zhijian; Non-executive Director Jing Huan; and Independent Non-executive Directors Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187480454","isCrawlerRequest":true}